The HeraBEAT foetal heart rate monitor. Source: HeraMED
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • HeraMED (HMD) partners with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States
  • The companies strike a binding term sheet that will see the HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites
  • During the first year, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license
  • The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months
  • Shares in HeraMED are up 25 per cent to 16 cents per share at 10:17 am AEST

Pregnancy care tech specialist HeraMED (HMD) has partnered with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring technology to customers in the United States.

The companies have signed a binding term sheet that will see HeraMED supply 1000 kits to expectant mothers at e-Lōvu’ partner healthcare provider sites.

The kits to be provided under the deal include the HeraBEAT foetal heart rate monitor and Bluetooth-connected blood pressure cuffs with HeraCARE connectivity, which allow future mothers to monitor their pregnancies.

During the first year of the deal, e-Lōvu will pay HeraMED about US$550,000 (A$787,000) for the technology and a HeraCARE license.

However, this is subject to e-Lōvu Health securing the required funding, which is expected at the end of the third quarter this year.

The first e-Lōvu site is expected to launch by the end of the year, with full deployment expected in the next six to twelve months.

Following the initial period, the companies plan to enter a long-term strategic partnership.

HeraMED CEO and Cofounder David Groberman said he saw great potential in the partnership.

“The deal clearly validates the advantages of our technology and business model and officially launches our commercialisation into the United States market,” Mr Groberman said.

Shares in HeraMED were up 25 per cent to 16 cents per share at 10:17 am AEST.

hmd by the numbers
More From The Market Online

All eyes on Prescient Therapeutics as it enters into trading halt

Prescient Therapeutics entered into a trading halt this morning and opened a placement opportunity for sophisticated…
HotCopper Daily Market Trends Graphic

Monday’s HotCopper trends: American Tungsten & Antimony, White Cliff Minerals, Motio and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…

Perpetual Resources has rig mobilisation underway at Igrejinha lithium project

Perpetual Resources says mobilisation is now underway for an approximately 1,500m diamond drilling program at the…

Lycopodium awarded EPCM contract for Greatland’s Havieron gold-copper project

Lycopodium has been awarded the EPCM contract for delivery of Greatland Resources' Havieron gold-copper project in…